PMID- 37276980 OWN - NLM STAT- MEDLINE DCOM- 20230807 LR - 20230807 IS - 1872-8227 (Electronic) IS - 0168-8227 (Linking) VI - 202 DP - 2023 Aug TI - Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry. PG - 110766 LID - S0168-8227(23)00529-6 [pii] LID - 10.1016/j.diabres.2023.110766 [doi] AB - AIMS: To analyze the association between chronic SGLT2-I treatment and development of contrast-induced acute kidney injury (CI-AKI) in diabetic patients with acute myocardial infarction (AMI) undergoing PCI. METHODS: Multicenter international registry of consecutive patients with type 2 diabetes mellitus (T2DM) and AMI undergoing PCI between 2018 and 2021. The study population was stratified by the presence of chronic kidney disease (CKD) and anti-diabetic therapy at admission (SGLT2-I versus non-SGLT2-I users). RESULTS: The study population consisted of 646 patients: 111 SGLT2-I users [28 (25.2%) with CKD] and 535 non-SGLT2-I users [221 (41.3%) with CKD]. The median age was 70 [61-79] years. SGLT2-I users exhibited significantly lower creatinine values at 72 h after PCI, both in the non-CKD and CKD stratum. The overall rate of CI-AKI was 76 (11.8%), significantly lower in SGLT2-I users compared to non-SGLT2-I patients (5.4% vs 13.1%, p = 0.022). This finding was also confirmed in patients without CKD (p = 0.040). In the CKD cohort, SGLT2-I users maintained significantly lower creatinine values at discharge. The use of SGLT2-I was an independent predictor of reduced rate of CI-AKI (OR 0.356; 95%CI 0.134-0.943, p = 0.038). CONCLUSION: In T2DM patients with AMI, the use of SGLT2-I was associated with a lower risk of CI-AKI, mostly in patients without CKD. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Paolisso, Pasquale AU - Paolisso P AD - Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium; Dept. of Advanced Biomedical Sciences, University Federico II, Naples, Italy. FAU - Bergamaschi, Luca AU - Bergamaschi L AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. FAU - Cesaro, Arturo AU - Cesaro A AD - Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy; Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy. FAU - Gallinoro, Emanuele AU - Gallinoro E AD - Clinical Cardiology and Cardiovascular Imaging Unit, Galeazzi-Sant'Ambrogio Hospital, IRCCS, Milan, Italy, Department of Biomedical and Clinical Sciences, University of Milan, Italy. FAU - Gragnano, Felice AU - Gragnano F AD - Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy; Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy. FAU - Sardu, Celestino AU - Sardu C AD - Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy. FAU - Mileva, Niya AU - Mileva N AD - Medical University of Sofia, Sofia, Bulgaria. FAU - Foa, Alberto AU - Foa A AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. FAU - Armillotta, Matteo AU - Armillotta M AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. FAU - Sansonetti, Angelo AU - Sansonetti A AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. FAU - Amicone, Sara AU - Amicone S AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. FAU - Impellizzeri, Andrea AU - Impellizzeri A AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. FAU - Belmonte, Marta AU - Belmonte M AD - Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium; Dept. of Advanced Biomedical Sciences, University Federico II, Naples, Italy. FAU - Esposito, Giuseppe AU - Esposito G AD - Dept. of Advanced Biomedical Sciences, University Federico II, Naples, Italy; Interventional Cardiology Unit, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy. FAU - Morici, Nuccia AU - Morici N AD - IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy. FAU - Andrea Oreglia, Jacopo AU - Andrea Oreglia J AD - Interventional Cardiology Unit, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy. FAU - Casella, Gianni AU - Casella G AD - Unit of Cardiology, Maggiore Hospital, Bologna, Italy. FAU - Mauro, Ciro AU - Mauro C AD - Department of Cardiology, Hospital Cardarelli, Naples, Italy. FAU - Vassilev, Dobrin AU - Vassilev D AD - Medica Cor Hospital, Russe, Bulgaria. FAU - Galie, Nazzareno AU - Galie N AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. FAU - Santulli, Gaetano AU - Santulli G AD - Dept. of Advanced Biomedical Sciences, University Federico II, Naples, Italy; International Translational Research and Medical Education (ITME) Consortium, Naples, Italy; Department of Medicine (Division of Cardiology) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein-Sinai Diabetes Research Center, The Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, NY, USA. FAU - Calabro, Paolo AU - Calabro P AD - Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy; Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy. FAU - Barbato, Emanuele AU - Barbato E AD - Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy. FAU - Marfella, Raffaele AU - Marfella R AD - Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy. FAU - Pizzi, Carmine AU - Pizzi C AD - Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Italy. Electronic address: carmine.pizzi@unibo.it. LA - eng PT - Journal Article PT - Multicenter Study DEP - 20230603 PL - Ireland TA - Diabetes Res Clin Pract JT - Diabetes research and clinical practice JID - 8508335 RN - 0 (Sodium-Glucose Transporter 2 Inhibitors) RN - AYI8EX34EU (Creatinine) SB - IM MH - Humans MH - Aged MH - *Diabetes Mellitus, Type 2/complications/drug therapy MH - *Sodium-Glucose Transporter 2 Inhibitors/adverse effects MH - *Percutaneous Coronary Intervention MH - Creatinine MH - *Myocardial Infarction MH - *Renal Insufficiency, Chronic/complications/drug therapy/epidemiology MH - *Acute Kidney Injury/chemically induced/epidemiology/complications MH - Registries MH - Risk Factors OTO - NOTNLM OT - Acute myocardial infarction OT - Chronic kidney disease OT - Contrast-induced-acute kidney injury OT - SGLT2-I COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/06/06 01:11 MHDA- 2023/08/07 06:41 CRDT- 2023/06/05 19:22 PHST- 2023/05/02 00:00 [received] PHST- 2023/05/29 00:00 [revised] PHST- 2023/05/31 00:00 [accepted] PHST- 2023/08/07 06:41 [medline] PHST- 2023/06/06 01:11 [pubmed] PHST- 2023/06/05 19:22 [entrez] AID - S0168-8227(23)00529-6 [pii] AID - 10.1016/j.diabres.2023.110766 [doi] PST - ppublish SO - Diabetes Res Clin Pract. 2023 Aug;202:110766. doi: 10.1016/j.diabres.2023.110766. Epub 2023 Jun 3.